Journey Medical [DERM] vs Haleon Plc - ADR [HLN] Detailed Stock Comparison

Journey Medical

NASDAQ

Haleon Plc - ADR

NYSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Journey Medical wins in 7 metrics, Haleon Plc - ADR wins in 11 metrics, with 0 ties. Haleon Plc - ADR appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Journey Medical	Haleon Plc - ADR	Better
P/E Ratio (TTM)	39.08	19.93	Haleon Plc - ADR
Price-to-Book Ratio	8.66	5.08	Haleon Plc - ADR
Debt-to-Equity Ratio	131.34	53.41	Haleon Plc - ADR
PEG Ratio	-6.64	21.36	Journey Medical
EV/EBITDA	-60.65	33.86	Journey Medical
Profit Margin (TTM)	-15.49%	13.81%	Haleon Plc - ADR
Operating Margin (TTM)	-19.16%	22.21%	Haleon Plc - ADR
EBITDA Margin (TTM)	N/A	22.21%	N/A
Return on Equity	-57.22%	9.38%	Haleon Plc - ADR
Return on Assets (TTM)	-5.86%	4.61%	Haleon Plc - ADR
Free Cash Flow (TTM)	$-24.13M	$2.67B	Haleon Plc - ADR
Dividend Yield	N/A	1.63%	N/A
1-Year Return	11.79%	-14.37%	Journey Medical
Price-to-Sales Ratio (TTM)	3.31	3.63	Journey Medical
Enterprise Value	$178.07M	$119.46B	Haleon Plc - ADR
EV/Revenue Ratio	3.16	8.07	Journey Medical
Gross Profit Margin (TTM)	67.09%	55.38%	Journey Medical
Revenue per Share (TTM)	$3	$2	Journey Medical
Earnings per Share (Diluted)	$-0.37	$0.45	Haleon Plc - ADR
Beta (Stock Volatility)	0.81	0.24	Haleon Plc - ADR

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Journey Medical vs Haleon Plc - ADR Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Journey Medical	0.69%	5.80%	2.53%	3.69%	16.99%	82.50%
Haleon Plc - ADR	-1.44%	1.83%	-9.02%	-13.45%	-12.60%	-5.93%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Journey Medical	11.79%	208.02%	-26.26%	-72.07%	-53.05%	-53.05%
Haleon Plc - ADR	-14.37%	45.81%	19.84%	19.84%	19.84%	19.84%

Performance & Financial Health Analysis: Journey Medical vs Haleon Plc - ADR

Metric	DERM	HLN
Market Information
Market Cap i	$186.80M	$41.72B
Market Cap Category	Micro cap	Large cap
10 Day Avg. Volume i	86,150	9,529,570
90 Day Avg. Volume i	125,937	8,844,817
Last Close	$7.30	$8.88
52 Week Range	$3.54 - $8.90	$8.71 - $11.42
% from 52W High	-17.98%	-22.24%
All-Time High	$38.75 (Feb 27, 2017)	$11.42 (Jun 02, 2025)
% from All-Time High	-81.16%	-22.24%
Growth Metrics
Quarterly Revenue Growth	0.01%	-0.01%
Quarterly Earnings Growth	0.01%	0.33%
Financial Health
Profit Margin (TTM) i	-0.15%	0.14%
Operating Margin (TTM) i	-0.19%	0.22%
Return on Equity (TTM) i	-0.57%	0.09%
Debt to Equity (MRQ) i	131.34	53.41
Cash & Liquidity
Book Value per Share (MRQ)	$0.82	$1.77
Cash per Share (MRQ)	$0.83	$0.08
Operating Cash Flow (TTM) i	$-2,706,000	$3.34B
Levered Free Cash Flow (TTM) i	$-14,288,125	$2.58B
Dividends
Last 12-Month Dividend Yield i	N/A	1.63%
Last 12-Month Dividend i	N/A	$0.17

Valuation & Enterprise Metrics Analysis: Journey Medical vs Haleon Plc - ADR

Metric	DERM	HLN
Price Ratios
P/E Ratio (TTM) i	39.08	19.93
Forward P/E i	-118.33	21.36
PEG Ratio i	-6.64	21.36
Price to Sales (TTM) i	3.31	3.63
Price to Book (MRQ) i	8.66	5.08
Market Capitalization
Market Capitalization i	$186.80M	$41.72B
Enterprise Value i	$178.07M	$119.46B
Enterprise Value Metrics
Enterprise to Revenue i	3.16	8.07
Enterprise to EBITDA i	-60.65	33.86
Risk & Other Metrics
Beta i	0.81	0.24
Book Value per Share (MRQ) i	$0.82	$1.77

Financial Statements Comparison: Journey Medical vs Haleon Plc - ADR

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	DERM	HLN
Revenue/Sales i	$15.01M	$3.72B
Cost of Goods Sold i	$4.94M	$1.66B
Gross Profit i	$10.07M	$2.06B
Research & Development i	$0	$105.17M
Operating Income (EBIT) i	$-2.88M	$471.91M
EBITDA i	$-1.65M	$488.09M
Pre-Tax Income i	$-3.74M	$388.31M
Income Tax i	$60,000	$88.99M
Net Income (Profit) i	$-3.80M	$299.32M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	DERM	HLN
Cash & Equivalents i	$21.07M	$911.46M
Total Current Assets i	$53.99M	$5.59B
Total Current Liabilities i	$40.22M	$6.42B
Long-Term Debt i	$23.20M	$10.30B
Total Shareholders Equity i	$21.54M	$21.57B
Retained Earnings i	$-91.10M	$36.76B
Property, Plant & Equipment i	$178,000	$2.52B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	DERM	HLN
Operating Cash Flow i	$-9.28M	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	$-2.83M	N/A
Debt Repayment i	$-625,000	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	DERM	HLN
Shares Short i	1.51M	15.71M
Short Ratio i	9.93	1.93
Short % of Float i	0.10%	0.00%
Average Daily Volume (10 Day) i	86,150	9,529,570
Average Daily Volume (90 Day) i	125,937	8,844,817
Shares Outstanding i	22.15M	12.25B
Float Shares i	12.81M	8.99B
% Held by Insiders i	0.33%	0.00%
% Held by Institutions i	0.33%	0.13%

Dividend Analysis & Yield Comparison: Journey Medical vs Haleon Plc - ADR

Metric	DERM	HLN
Last 12-Month Dividend i	N/A	$0.17
Last 12-Month Dividend Yield i	N/A	1.63%
3-Year Avg Annual Dividend i	N/A	$0.11
3-Year Avg Dividend Yield i	N/A	0.91%
3-Year Total Dividends i	N/A	$0.34
Ex-Dividend Date	N/A	Apr 25, 2025